Researchers at the University of Chicago have successfully captured detailed images of adhesion G protein-coupled receptors, ...

Researchers at the University of Chicago have captured complete images of adhesion G protein-coupled receptors and an ...

GPCR Therapeutics, the partner with Exicure in this MoU, is a South Korean drug development company specializing in GPCR (G Protein-Coupled Receptor, GPCR), which represents over one-third of all drug ...

After years of restructuring, Chicago-based Exicure has South Korean majority ownership and is buying the U.S. arm of a South ...

Exicure, Inc. (Nasdaq: XCUR, “Exicure”, “the Company”), has announced the signing of a Memorandum of Understanding (MOU) with ...

Structure Therapeutics Inc. (NASDAQ:GPCR – Get Free Report) rose 5.6% on Thursday . The company traded as high as $29.87 and last traded at $29.84. Approximately 85,014 shares changed hands during mid ...

Micro-cap early-stage biotech Exicure, Inc.’s ($XCUR) shares rose sharply in premarket trading on Friday following a deal to ...

Breast cancer remains a leading health crisis worldwide, claiming the lives of approximately 685,000 women in 2020 alone.

Principal Financial Group Inc. increased its holdings in shares of Structure Therapeutics Inc. (NASDAQ:GPCR – Free Report) by 230.0% in the third quarter, according to the company in its most recent ...

After hours: December 26 at 6:56:47 p.m. EST ...

Peptides, as versatile biological molecules, have garnered significant attention in scientific research due to their ...

“Chronic abdominal pain is complex because it involves multiple mechanisms, including inflammation, altered gut motility, and heightened sensitivity of the nervous system,” Muttenhalter told IE. “The ...